Asthma Flashcards

1
Q

What are some parts of the definition for asthma

A

chronic inflammatory disorder with mast cells, eosinophils, CD4 t lymphocytes. causes wheezes, breathlessness, chest tightness, and cough but not really chest pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 critical components of asthma

A
  1. Episodic cough, wheeze, SOB, chest tightness
  2. Variable airflow obstruction that reverses sponatenously or with treatment
  3. Increased bronchial hyperreactivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 critical measures of asthma severity

A

impairment of activities because of symptoms

2. risk of exacerpabation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Difference btw first presentation of asthma in adults and kids

A

kids: atopic march of eczema, food allergies, rhinitis, and asthma. Occasionally preceded by RSV infection.
adults: may not require allergic history. Often preceded by a hx of recent infection that settled in the chest. For adults, rule out occupational/environmental exposures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the definition of severe asthma? Important sequelae/considerations?

A

Severe: attacks and symptoms every day despite medications. Increased risk of acute decompensation and death. the biggest risk for fatal astham is prior hospitalization or ICU admission for asthma. may be because these people’s bodies don’t recognize signs of hypoxia and hypercarbia as well as other people’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

One cause of fatal asthma in kids

A

mucus plugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Airflow obstruction: What is happening physically?

A

symptoms: wheezing and other expiratory limitation from smooth muscle constriction, mucus production, and airway collapse. segment of the airway collapses with high upstream pressure and low downstream pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aiflow obstruction tests

A

FEV1/FVC ratio below 70%. reverses with bronchodilators: increase of FEV1 greater than or equal to 12% and 200 mL in volume.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you test for bronchial hyper responsiveness? Agents used?

A
broncho provocation studies.  inhale something that is irritating and do serial FEV1 measurements.  
Use methacholine (direct smooth muscle constrictor) or mannitol (indirect irritant).  
Normal people should be ok, but asthmatics tend to show a decrease in FEV1 as you give more irritant.
test is 85% sensitive.  may get false negatives with medication use; hyperreactivity may also wax and wane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is airway remodeling

A

structural change to the airway that occurs after long-term chronic asthma. see subepithelial collagen deposition, more smooth muscle mass, thickened epithelium. this is basically a form of irreversible obstruction, as in COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors are made by TH2 lymphocytes. Which ones casuse similar effects?

A

IL4, IL5, and IL13. IL4 and IL13 grouped together.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effects of IL5

A

increased eosinophils –> incr. leukotrienes (from arachidonic acid) and increased granules. Ultimately, this causes vascular leak/edema, mucus secretion, and smooth muscle contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of IL4 and IL13

A

two systems:

  1. epithelium –> increased mucus chemokines and inducible nitric oxide synthetase. Leads to increased mucus and increased nitric oxide
  2. B cells –> IgE –> activated mast cells –> mast cell degranulation in presence of an allergen –> bronchospasm, edema, air flow constriction, and hyper-responsiveness.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Exhaled NO

A

because IL4 and IL13 stimulate the epithelium to make inducible nitric oxide synthetase, many asthmatics have elevated exhaled NO. may reflect airway inflammation. not very sensitive, but quite specific. exhaled NO >50 ppm usually means asthma. Good for monitoring therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Short term pharmacological therapies for asthma. goals and classes.

A

relieve bronchospasm. include inhaled beta agonists, epinepherine derivatives, and anti-cholinergis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Long term pharmacologic therapies for asthma. goals and classes

A

to treat inflammation. inhaled corticosteroids, systemic steroids, lekuotriene modifiers, and anti-IgE antibodies

17
Q

Inhaled beta agonists: types, duration, examples

A

usually dry powder inhalers
may be short or long acting
short lasts 4-6 hrs: albuterol and levobuterol
long: 12-24 hrs. lipid part for membrane insertion. think salmeterol.
Beta 2 G protein coupled receptor (7 membrane pass) relaxes bronchial smooth muscle through PKA activation.

18
Q

What is the first drug for mild intermittent asthma

A

short acting beta agonist

19
Q

What should I know about long acting beta agonists?

A

based on SMART study, may cause increased problems, esp. in African Americans, when compared with other drugs. Therefore, long acting beta agonists are NOT used as monotherapy. May be used in combination with inhaled steroids for moderate asthma

20
Q

Inhaled steroids: when use, effects.

A

first line therapy for persistent asthma. may even reduce remodeling but we don’t know for sure.
cause decreased mucus chemokines, decr. IgE production, decreased IL5, and decreased eosinophils.
increase neutrophils.

21
Q

Drawbacks of corticosteroids.

A

decr. bone mass, decr. height, cataracts.

also, very expensive. none are generic.

22
Q

Name of an inhaled corticosteroid

A

symbicot, advair

23
Q

Leukotriene antagonists.

A

singular and zyflo

24
Q

Targets for antibody asthma treatments. Other new treatments?

A
  1. Xolair targets IgE and is already on the market
    in future:
    targets against IL5 and IL13.
    also, things that zap unnecessary bronchiole smooth muscle.